Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study-Reference-Cited by-同舟云学术

Impact of Abiraterone Acetate plus Prednisone or Enzalutamide on Patient-reported Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer: Final 12-mo Analysis from the Observational AQUARiUS Study

Published:2020-03 Issue:3 Volume:77 Page:380-387
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Thiery-Vuillemin Antoine,Poulsen Mads Hvid,Lagneau Edouard,Ploussard Guillaume,Birtle Alison,Dourthe Louis-Marie,Beal-Ardisson Dominique,Pintus Elias,Trepiakas Redas,Lefresne Florence,Lukac Martin,Van Sanden Suzy,Pissart Genevieve,Reid Alison

Funder

Janssen EMEA

Publisher

Elsevier BV

Subject

Urology

Reference21 articles.

1. The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment;Dueregger;Nutrients,2014

2. Navigating the evolving therapeutic landscape in advanced prostate cancer;Crawford;Urol Oncol,2017

3. Characterising the castration-resistant prostate cancer population: a systematic review;Kirby;Int J Clin Pract,2011

4. Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science;Nussbaum;Prostate Cancer Prostatic Dis,2016

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain Metabolic Correlates of the Off-Target Effects of Enzalutamide on the Central Nervous System of Patients with Advanced Prostate Cancer;Journal of Nuclear Medicine;2024-04-11

2. A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately?;Critical Reviews in Oncology/Hematology;2024-04

3. A Prospective Randomised Trial to Determine the Effect of a Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer;European Urology Oncology;2024-03

4. Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta‐analysis;Cancer;2024-02-02

5. Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid review;BMJ Oncology;2024-02